Similar Articles
81 Risk factors and urinary biomarkers of non-albuminuric and albuminuric chronic kidney disease in patients with type 2 diabetes
82 Organ-associated pseudosarcomatous myofibroblastic proliferation with ossification in the lower pole of the kidney mimicking renal pelvic carcinoma: A case report
83 Pseudothrombus deposition accompanied with minimal change nephrotic syndrome and chronic kidney disease in a patient with Waldenström's macroglobulinemia: A case report
84 Single strain probiotics for dyslipidemia, fatty liver, and obesity: A systematic review and meta-analysis
85 Proton pump inhibitors and adverse effects in kidney transplant recipients: A meta-analysis
86 Anti-hepatitis C virus therapy in chronic kidney disease patients improves long-term renal and patient survivals
87 Management of diabetic dyslipidemia: An update
88 Integrated metabolomic profiling for analysis of antilipidemic effects of Polygonatum kingianum extract on dyslipidemia in rats
89 Oral alkali therapy and the management of metabolic acidosis of chronic kidney disease: A narrative literature review
90 Nationwide cohort study suggests that nucleos(t)ide analogue therapy decreases dialysis risk in Taiwanese chronic kidney disease patients acquiring hepatitis B virus infection
© 2004-2025 Baishideng Publishing Group Inc. All rights reserved. 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA